We are live on ! Find out more

Mid Cap Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
TARS icon
101
Tarsus Pharmaceuticals
TARS
$2.97B
$2.97B $67.76 4.58%
PLSE icon
102
Pulse Biosciences
PLSE
$2.96B
$2.96B $41.51 2.12%
ACHC icon
103
Acadia Healthcare
ACHC
$2.96B
$2.96B $31.78 0.79%
IMNM icon
104
Immunome
IMNM
$2.91B
$2.91B $25.69 2.64%
IOVA icon
105
Iovance Biotherapeutics
IOVA
$2.9B
$2.9B $6.40 0.95%
ALHC icon
106
Alignment Healthcare
ALHC
$2.86B
$2.86B $13.78 4.11%
PRVA icon
107
Privia Health
PRVA
$2.86B
$2.86B $22.37 0.36%
ABCL icon
108
AbCellera Biologics
ABCL
$2.85B
$2.85B $9.34 34.8%
BEAM icon
109
Beam Therapeutics
BEAM
$2.82B
$2.82B $27.28 0.73%
SUPN icon
110
Supernus Pharmaceuticals
SUPN
$2.74B
$2.74B $47.07 1.2%
KOD icon
111
Kodiak Sciences
KOD
$2.72B
$2.72B $43.40 4.34%
NRIX icon
112
Nurix Therapeutics
NRIX
$2.69B
$2.69B $25.88 1.37%
ATAI icon
113
AtaiBeckley Inc
ATAI
$2.68B
$2.68B $7.25 0%
ZLAB icon
114
Zai Lab
ZLAB
$2.65B
$2.65B $23.57 1.07%
RARE icon
115
Ultragenyx Pharmaceutical
RARE
$2.64B
$2.64B $26.80 3.43%
GRDN
116
Guardian Pharmacy Services
GRDN
$2.63B
$2.63B $41.47 5.38%
VRDN icon
117
Viridian Therapeutics
VRDN
$2.61B
$2.61B $23.06 2.25%
RGC icon
118
Regencell Bioscience
RGC
$2.61B
$2.61B $5.28 2.4%
AXGN icon
119
Axogen
AXGN
$2.59B
$2.59B $48.22 3.86%
BFLY icon
120
Butterfly Network
BFLY
$2.58B
$2.58B $9.70 9.85%
TRVI icon
121
Trevi Therapeutics
TRVI
$2.54B
$2.54B $17.80 3.84%
HTFL
122
Heartflow Inc
HTFL
$2.53B
$2.53B $29.35 1.84%
NKTR icon
123
Nektar Therapeutics
NKTR
$2.53B
$2.53B $74.86 2.12%
AMLX icon
124
Amylyx Pharmaceuticals
AMLX
$2.53B
$2.53B $22.67 0.66%
UFPT icon
125
UFP Technologies
UFPT
$2.51B
$2.51B $325 3.5%
3 4
5
6 7

Mid Cap Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 164 mid cap Healthcare stocks — companies in the Healthcare sector with a market cap between $2B and $10B — worth a combined $748B.

The largest by market cap are Tempus AI (TEM) at $9.93B, Insulet (PODD) at $9.91B and Henry Schein (HSIC) at $9.82B.

Among institutional investors, ImmunityBio (IBRX) drew the most net new fund positions in Q1 2026: 145 funds opened new positions, taking total fund holders up 109 (39%) quarter-over-quarter.

  • Combined market cap: $748B across 164 stocks.
  • Mid Cap: market cap between $2B and $10B.
  • Largest constituent: Tempus AI (TEM), $9.93B market cap.
  • Most net new fund positions in Q1 2026: ImmunityBio (IBRX), +109 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.